Doctors have an overwhelming amount of individual patient data and medical research at their disposal to make diagnoses and ...
Zacks.com on MSN2h
Pharma Stock Roundup: FDA Updates for JNJ, GSK, PFE, NVO's Expanded DealThis week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...
Preparing cancer patients for difficult decisions is an oncologist's job. They don't always remember to do it, however.
Bagsværd, Denmark Friday, January 10, 2025, 11:00 Hrs [IST] ...
A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...
Nearly 30% of the funding poured into healthcare startups last year, including for biotechs, went to companies leveraging ...
Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...
In November 2023, the estates of two now-deceased policyholders sued the US health insurer, United Healthcare, for deploying ...
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Innovaccer has raised a $275M Series F from investors including B Capital Group, Banner Health, Danaher Ventures, Generation ...
Shares of Novo Nordisk NVO gained 2.8% on Wednesday likely because the analysts at UBS upgraded the company’s rating from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback